1 min read
Treace Medical Concepts Q3 Revenue Falls 3.8% to $48.3 Million
The medical device company’s GAAP loss was 19 cents per share, 6 cents better than estimates. Its net loss improved 23% to $12.6 million.

Treace Medical Concepts, Inc. (TMCI) posted third-quarter 2026 revenue of $48.3 million, down 3.8% from a year earlier but $590,000 above estimates.
The company recorded a GAAP loss of 19 cents per share, 6 cents better than estimates. Its net loss improved 23% to $12.6 million.